Dystrophic lesions of the cornea and retina, including hereditary tapetoretinal degeneration; senile, diabetic, traumatic and radiation cataracts; as a means of stimulating reparative processes in corneal injuries; as an additional tool in the treatment of open-angle glaucoma.
Composition and form of release
Taufon is made in the form of eye drops and eye films. The active ingredient is taurine.
Taufon in eye drops is used in conjunction with other medications in therapy for:
- corneal injuries;
- corneal dystrophy;
- primary open-angle glaucoma;
Eye films Taufon are used to stimulate the recovery processes in the tissues of the eye in trauma and corneal degeneration.
Taufon in drops and eye films is not used in the treatment of persons under the age of 18, as well as those who suffer from hypersensitivity to its components. In addition, the use of eye films is not possible if the patient has a history of recurrent corneal erosions or a predisposition to drug allergies.
Application during pregnancy and lactation
The use of Taufon in the therapy of nursing and pregnant women is carried out with great caution and only in those cases where the alleged benefit outweighs the risk to the fetus, since the safety profile of the drug for this category of patients has not actually been studied.
Method of administration and dosage
Taufon in eye drops is used to instill the eyes in 1 or 2 drops from 2 to 4 times a day. The duration of therapy is three months. Re-treatment with the drug is possible only 30 days after its last use.
In the treatment of dystrophic corneal lesions, the drug is prescribed 1 – 2 drops 2 or 4 times a day. In the treatment of open-angle glaucoma, Taufon is instilled into each eye 1 – 2 drops twice a day for 6 months.
Taufon in eye films is intended for local application. Before use, with the help of clean ophthalmic tweezers, the film is removed from the package and placed in the lower eyelid. After laying the film, you should keep the eye in a motionless state for 30 to 60 seconds, which will contribute to its high-quality softening. When treating corneal dystrophy, the drug is used every 1 or 2 days. The recommended dose of the drug is from 10 to 15 films. When treating corneal injuries, eye films are placed 1 time per day for 10 days.
At the moment, cases of overdose with Taufon have not been officially registered.
The use of Taufon is sometimes accompanied by the development of local allergic reactions, manifested by a slight reddening of the conjunctiva of the eyes. If, when using films, there is a feeling of a foreign body in the eye, which does not disappear within 5 minutes, then the drug is recommended to be removed.
If, when using Taufon, you experience side effects that are not described in the instructions for the drug, it is recommended that you inform your doctor about them.
Storage conditions and periods
Taufon should be taken in places inaccessible to children at temperatures no higher than 25 degrees. The shelf life of the drug contained in dropper tubes is 2 years, in a dropper bottle – 3 years, eye films – 2 years. Regardless of the dosage form, the drug is strictly forbidden to use after the expiration date.